---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013396"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:57:52.779887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio doubles HQ leased space to 13,242 RSF; lease extended to Feb 2033

## Summary
- Lease amendment doubles space from 6,708 to 13,242 rentable square feet on Building's 2nd floor.
- Term extended seven years to February 28, 2033; annual base rent approx. $330,000 ($24.75/RSF).
- Relocation from 4th floor to 2nd floor effective June 1, 2025; prior lease terminated.
- Employees from Philadelphia R&D center to be relocated after its lease expires June 2025.

## SEC filing metadata
- accession: 0001641172-25-013396
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/0001641172-25-013396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013396
- JSON: https://secwatch.observer/filing/0001641172-25-013396.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013396.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.